Invesco’s Kiora Pharmaceuticals KPRX Stock Holding History

Invesco’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2	Closed	-$3K	–	3851
2018 Q3	$3K	Hold	2	–	–	﹤0.01%	3878
2018 Q2	$6K	Buy	+2	New	+$5.64K	﹤0.01%	3863

Other funds holding KPRX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco's KPRX Position: Q4 2018 in Review

Invesco sold out of Kiora Pharmaceuticals (KPRX) in Q4 2018, closing a stake of 2 shares — an estimated $3K sold.

Invesco first reported a position in KPRX in Q2 2018 and held it in 2 quarters. The position peaked at $6K in Q2 2018. 13 funds tracked by Wall St. Rank hold KPRX as of Q4 2018.

Invesco reported no remaining Kiora Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Invesco sold 2 Kiora Pharmaceuticals shares in Q4 2018, an estimated $3K.
Invesco first reported a position in Kiora Pharmaceuticals in Q2 2018 and held it in 2 quarters.
Invesco's Kiora Pharmaceuticals position peaked at $6K in Q2 2018.
13 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q4 2018.

Based on Invesco's 13F filing for Q4 2018, filed 14 Feb 2019.